220 related articles for article (PubMed ID: 38383366)
1. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
Agyare Gyane F; Modey E; Maya E; Bonney EY; Abaidoo-Myles A; Paintsil E; Torpey K
PLoS One; 2024; 19(5):e0303535. PubMed ID: 38814956
[TBL] [Abstract][Full Text] [Related]
3. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
[TBL] [Abstract][Full Text] [Related]
4. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
Ferré VM; Ekouevi DK; Gbeasor-Komlanvi FA; Collin G; Le Hingrat Q; Tchounga B; Salou M; Descamps D; Charpentier C; Dagnra AC
Clin Microbiol Infect; 2019 Dec; 25(12):1560.e1-1560.e7. PubMed ID: 31051265
[TBL] [Abstract][Full Text] [Related]
6. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.
Rodrigues LLS; Morgado MG; Sahasrabuddhe VV; De Paula VS; Oliveira NS; Chavez-Juan E; Da Silva DM; Kast WM; Nicol AF; Pilotto JH
Gynecol Oncol; 2018 Oct; 151(1):102-110. PubMed ID: 30087059
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
[TBL] [Abstract][Full Text] [Related]
9. Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
Kirabira J; Kayondo M; Bawakanya SM; Nsubuga EJ; Yarine F; Namuli A; Namugumya R; Natulinda CH; Atwine R; Birungi A; Lugobe HM; Tibaijuka L; Kisombo D; Jjuuko M; Agaba DC; Saturday P; Atupele SM; Tumusiime M; Migisha R; Kajabwangu R
BMC Womens Health; 2024 Apr; 24(1):266. PubMed ID: 38678278
[TBL] [Abstract][Full Text] [Related]
10. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
Wagner A; Skof AS; Sehouli J; Richter R; Henrich W; von Weizsäcker K; Siedentopf JP; Chekerov R; Kaufmann AM; Rohr I
Int J Gynecol Cancer; 2022 Jun; 32(6):716-723. PubMed ID: 35354606
[TBL] [Abstract][Full Text] [Related]
11. Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy.
Nakisige C; Adams SV; Namirembe C; Okoche L; Ferrenberg J; Towlerton A; Larsen A; Orem J; Casper C; Frenkel L; Uldrick TS
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):333-342. PubMed ID: 35195571
[TBL] [Abstract][Full Text] [Related]
12. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.
Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K
PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of high-risk human papillomavirus infection and associated factors among women of reproductive age attending a rural teaching hospital in western Uganda.
Nang DW; Tukirinawe H; Okello M; Tayebwa B; Theophilus P; Sikakulya FK; Fajardo Y; Afodun AM; Kajabwangu R
BMC Womens Health; 2023 Apr; 23(1):209. PubMed ID: 37118735
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
[TBL] [Abstract][Full Text] [Related]
15. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
[TBL] [Abstract][Full Text] [Related]
16. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
[TBL] [Abstract][Full Text] [Related]
17. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
[TBL] [Abstract][Full Text] [Related]
18. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
19. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
Metz CK; Skof AS; Sehouli J; Siedentopf JP; Gebert P; Weiss F; Alba Alejandre I; Heinrich-Rohr M; Weizsaecker K; Henrich W; Kaufmann AM; Rohr I
Arch Gynecol Obstet; 2023 Jul; 308(1):207-218. PubMed ID: 36576558
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
Tiiti TA; Mashishi TL; Nkwinika VV; Benoy I; Selabe SG; Bogers J; Lebelo RL
Virol J; 2021 Sep; 18(1):192. PubMed ID: 34556128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]